Virax Biolabs Group Ltd Cost Of Sales
Virax Biolabs Group Ltd (VRAX) reported Cost Of Sales of $59.40 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Expense Statement › Cost of Sales
ifrs-full:CostOfSales · last filed 2025-07-02
| Period end | Cost Of Sales 12 month |
|---|---|
| 2025-03-31 | $59.40K 20-F · filed 2025-07-02 |
| 2024-03-31 | $105.83K 20-F · filed 2025-07-02 |
| 2023-03-31 | $9.93K 20-F · filed 2025-07-02 |
| 2021-03-31 | $133.25K 20-F · filed 2022-08-12 |